PAYAL PATEL: Open Payments
NPI 1639850126 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 29 payments from 11 companies in 2025. Trend: 2023 $145 · 2024 $1,071 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $185 |
| Procept Biorobotics Corporation | 2 | $133 |
| Sumitomo Pharma America, Inc. | 5 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $52 |
| ACCORD HEALTHCARE, INC. | 2 | $35 |
| Novo Nordisk Inc | 1 | $29 |
| Dendreon Pharmaceuticals LLC | 1 | $25 |
| IMMUNITYBIO, INC. | 1 | $25 |
| Teleflex LLC | 1 | $23 |
Products named: Xtandi, AQUABEAM ROBOTIC SYSTEM, GEMTESA, Nubeqa, ERLEADA, Camcevi, ORGOVYX, Rybelsus.
Industry payments across WI — which companies pay providers there.
